WallStreetZenWallStreetZen

NASDAQ: COCH
Envoy Medical Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for COCH

Based on 1 analyst offering 12 month price targets for Envoy Medical Inc

Min Forecast
$9.50+1,080.12%
Avg Forecast
$9.50+1,080.12%
Max Forecast
$9.50+1,080.12%

Should I buy or sell COCH stock?

Based on 1 analyst offering ratings for Envoy Medical Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their COCH stock forecasts and price targets.

COCH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-27

1 of 1

Forecast return on equity

Is COCH forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is COCH forecast to generate an efficient return on assets?

Company
-279.38%
Industry
9.93%
COCH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

COCH earnings per share forecast

What is COCH's earnings per share in the next 2 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$1.23
Avg 2 year Forecast
-$1.29

COCH revenue forecast

What is COCH's revenue in the next 2 years based on estimates from 5 analysts?

Avg 1 year Forecast
$233.2k+5.06%
Avg 2 year Forecast
$306.0k+37.84%
COCH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

COCH revenue growth forecast

How is COCH forecast to perform vs Medical Devices companies and vs the US market?

Company
5.06%
Industry
6.45%
Market
1,359.42%
COCH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
COCH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

COCH vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
COCH$0.81$9.50+1,080.12%Buy
IRIX$1.01N/AN/A
AIMD$3.62N/AN/A
VVOS$2.60$6.50+150.00%Buy
ADGM$1.27N/AN/A
View Top Medical Device Stocks

Envoy Medical Stock Forecast FAQ

Is Envoy Medical Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: COCH) stock is to Buy COCH stock.

Out of 1 analyst, 0 (0%) are recommending COCH as a Strong Buy, 1 (100%) are recommending COCH as a Buy, 0 (0%) are recommending COCH as a Hold, 0 (0%) are recommending COCH as a Sell, and 0 (0%) are recommending COCH as a Strong Sell.

If you're new to stock investing, here's how to buy Envoy Medical stock.

What is COCH's earnings growth forecast for 2025-2026?

(NASDAQ: COCH) Envoy Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 28.75%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,752.86%.

Envoy Medical's earnings in 2025 is -$28,204,000.On average, 5 Wall Street analysts forecast COCH's earnings for 2025 to be -$26,414,792, with the lowest COCH earnings forecast at -$26,784,952, and the highest COCH earnings forecast at -$25,534,586.

In 2026, COCH is forecast to generate -$27,658,702 in earnings, with the lowest earnings forecast at -$28,261,288 and the highest earnings forecast at -$26,664,435.

What is COCH's revenue growth forecast for 2025-2026?

(NASDAQ: COCH) Envoy Medical's forecast annual revenue growth rate of 5.06% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,359.42%.

Envoy Medical's revenue in 2025 is $222,000.On average, 5 Wall Street analysts forecast COCH's revenue for 2025 to be $5,019,607, with the lowest COCH revenue forecast at $3,922,835, and the highest COCH revenue forecast at $6,779,094.

In 2026, COCH is forecast to generate $6,585,405 in revenue, with the lowest revenue forecast at $4,218,103 and the highest revenue forecast at $9,038,791.

What is COCH's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: COCH) forecast ROA is -279.38%, which is lower than the forecast US Medical Devices industry average of 9.93%.

What is COCH's Price Target?

According to 1 Wall Street analyst that have issued a 1 year COCH price target, the average COCH price target is $9.50, with the highest COCH stock price forecast at $9.50 and the lowest COCH stock price forecast at $9.50.

The Wall Street analyst predicted that Envoy Medical's share price could reach $9.50 by May 27, 2026. The average Envoy Medical stock price prediction forecasts a potential upside of 1,080.12% from the current COCH share price of $0.81.

What is COCH's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: COCH) Envoy Medical's current Earnings Per Share (EPS) is -$1.44. On average, analysts forecast that COCH's EPS will be -$1.23 for 2025, with the lowest EPS forecast at -$1.24, and the highest EPS forecast at -$1.19. In 2026, COCH's EPS is forecast to hit -$1.29 (min: -$1.31, max: -$1.24).

What is COCH's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: COCH) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.